ロード中...
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study
BACKGROUND: Fixed-combination calcipotriol 50 μg/g plus betamethasone 0.5 mg/g (Cal/BD) aerosol foam is a new topical treatment for psoriasis. Although moderate-to-severe psoriasis is typically treated with systemic/biologic therapies, a topical treatment that is efficacious in these patients may be...
保存先:
| 出版年: | Am J Clin Dermatol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422452/ https://ncbi.nlm.nih.gov/pubmed/28236223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-017-0258-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|